PALATINE, Ill., July 30, 2008 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (Nasdaq:ACUR) today reported 2008 second quarter net income of $6.9 million, or $0.13 per diluted share compared to a net loss of $2.2 million, or a $0.06 loss per share for the same quarter in 2007. For the six month period ended June 30, 2008, the Company reported net income of $14.3 million, or $0.28 per diluted share compared to a net loss of $11.4 million or a $0.32 loss per share for 2007.
